Satish Kumar

Satish Kumar

Auto-generated profile, based on publicly available information

Satish Kumar

School of Biotechnology, Kalinga Institute of Industrial Technology, Patia, Bhubaneswar 751024, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2016 in Scientific Reports
Verified
Journal Article
Open access
SSSridhar Sanyasi
Sridhar Sanyasi
RMRakesh Kumar Majhi
Rakesh Kumar Majhi
SKSatish Kumar
Satish Kumar
MMMitali Mishra
Mitali Mishra
AGArnab Ghosh
Arnab Ghosh
LGLuna Goswami
Luna Goswami
Development of effective anti-microbial therapeutics has been hindered by the emergence of bacterial strains with multi-drug resistance and biofilm formation capabilities. In this article, we report an efficient green synthesis of silver nanoparticle (AgNP) by in situ reduction and capping with a semi-synthetic polysaccharide-based biopolymer (carboxymethyl tamarind polysaccharide). The CMT-capped AgNPs were characterized by UV, DLS, FE-SEM, EDX and HR-TEM. These AgNPs have average particle size of ~20–40 nm, and show long time stability, indicated by their unchanged SPR and Zeta-potential values. These AgNPs inhibit growth and biofilm formation of both Gram positive (B. subtilis) and Gram negative (E. coli and Salmonella typhimurium) bacterial strains even at concentrations much lower than the minimum inhibitory concentration (MIC) breakpoints of antibiotics, but show reduced or no cytotoxicity against mammalian cells. These AgNPs alter expression and positioning of bacterial cytoskeletal proteins FtsZ and FtsA. CMT-capped AgNPs can effectively block growth of several clinical isolates and MDR strains representing different genera and resistant towards multiple antibiotics belonging to different classes. We propose that the CMT-capped AgNPs can have potential bio-medical application against multi-drug-resistant microbes with minimal cytotoxicity towards mammalian cells.

30 October 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SKSatish Kumar
Satish Kumar
RMRakesh Kumar Majhi
Rakesh Kumar Majhi
ASAbhishek Singh
Abhishek Singh
MMMitali Mishra
Mitali Mishra
ATAnkit Tiwari
Ankit Tiwari
CGChandan Goswami
Chandan Goswami

4 May 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
MMMitali Mishra
Mitali Mishra
SKSatish Kumar
Satish Kumar
RMRakesh K. Majhi
Rakesh K. Majhi
LGLuna Goswami
Luna Goswami
CGChandan Goswami
Chandan Goswami
HMHarapriya Mohapatra
Harapriya Mohapatra
Antibacterial therapy is of paramount importance in treatment of several acute and chronic infectious diseases caused by pathogens. Over the years extensive use and misuse of antimicrobial agents has led to emergence of multidrug resistant (MDR) and extensive drug resistant (XDR) pathogens. This drastic escalation in resistant phenotype has limited the efficacy of available therapeutic options. Thus, the need of the hour is to look for alternative therapeutic approaches to mitigate healthcare concerns caused due to MDR bacterial infections. Nanoparticles have gathered much attention as potential candidates for antibacterial therapy. Equipped with advantages of, wide spectrum bactericidal activity at very low dosage, inhibitor of biofilm formation and ease of permeability, nanoparticles have been considered as leading therapeutic candidates to curtail infections resulting from MDR bacteria. However, substrate non-specificity of efflux pumps, particularly those belonging to resistance nodulation division super family, have been reported to reduce efficacy of many potent antibacterial therapeutic drugs. Previously, we had reported antibacterial activity of polysaccharide-capped silver nanoparticles (AgNPs) toward MDR bacteria. We showed that AgNPs inhibits biofilm formation and alters expression of cytoskeletal proteins FtsZ and FtsA, with minimal cytotoxicity toward mammalian cells. In the present study, we report no reduction in antibacterial efficacy of silver nanoparticles in presence of AcrAB-TolC efflux pump proteins. Antibacterial tests were performed according to CLSI macrobroth dilution method, which revealed that both silver nanoparticles exhibited bactericidal activity at very low concentrations. Further, immunoblotting results indicated that both the nanoparticles modulate the transporter AcrB protein expression. However, expression of the membrane fusion protein AcrA did show a significant increase after exposure to AgNPs. Our results indicate that both silver nanoparticles are effective in eliminating MDR Enterobacter cloacae isolates and their action was not inhibited by AcrAB-TolC efflux protein expression. As such, the above nanoparticles have strong potential to be used as effective and alternate therapeutic candidates to combat MDR gram-negative Enterobacterial pathogens.

1 June 2018 in Carbohydrate Polymers
Verified
Journal Article
Closed access
PCPriyanka Choudhury
Priyanka Choudhury
SKSatish Kumar
Satish Kumar
ASAbhishek Singh
Abhishek Singh
AKAshutosh Kumar
Ashutosh Kumar
NKNavneet Kaur
Navneet Kaur
LGLuna Goswami
Luna Goswami

21 October 2016 in Macromolecular Bioscience
Verified
Journal Article
Closed access
PDF file
SSSridhar Sanyasi
Sridhar Sanyasi
SKSatish Kumar
Satish Kumar
AGArijit Ghosh
Arijit Ghosh
RMRakesh Kumar Majhi
Rakesh Kumar Majhi
NKNavneet Kaur
Navneet Kaur
LGLuna Goswami
Luna Goswami

9 March 2022 in ACS Omega
Verified
Journal Article
Open access
RCRanabir Chakraborty
Ranabir Chakraborty
TATusar Kanta Acharya
Tusar Kanta Acharya
NTNikhil Tiwari
Nikhil Tiwari
RMRakesh Kumar Majhi
Rakesh Kumar Majhi
SKSatish Kumar
Satish Kumar
CGChandan Goswami
Chandan Goswami
Bone defects, including bone loss due to increased osteoclast activity, have become a global health-related issue. Osteoclasts attach to the bone matrix and resorb the same, playing a vital role in bone remodeling. Ca2+ homeostasis plays a pivotal role in the differentiation and maturation of osteoclasts. In this work, we examined the role of TRPV1, a nonselective cation channel, in osteoclast function and differentiation. We demonstrate that endogenous TRPV1 is functional and causes Ca2+ influx upon activation with pharmacological activators [resiniferatoxin (RTX) and capsaicin] at nanomolar concentration, which enhances the generation of osteoclasts, whereas the TRPV1 inhibitor (5′-IRTX) reduces osteoclast differentiation. Activation of TRPV1 upregulates tartrate-resistant acid phosphatase activity and the expression of cathepsin K and calcitonin receptor genes, whereas TRPV1 inhibition reverses this effect. The slow release of capsaicin or RTX at a nanomolar concentration from a polysaccharide-based hydrogel enhances bone marrow macrophage (BMM) differentiation into osteoclasts whereas release of 5′-IRTX, an inhibitor of TRPV1, prevents macrophage fusion and osteoclast formation. We also characterize several subcellular parameters, including reactive oxygen (ROS) and nitrogen (RNS) species in the cytosol, mitochondrial, and lysosomal profiles in BMMs. ROS were found to be unaltered upon TRPV1 modulation. NO, however, had elevated levels upon RTX-mediated TRPV1 activation. Capsaicin altered mitochondrial membrane potential (ΔΨm) of BMMs but not 5′-IRTX. Channel modulation had no significant impact on cytosolic pH but significantly altered the pH of lysosomes, making these organelles less acidic. Since BMMs are precursors for osteoclasts, our findings of the cellular physiology of these cells may have broad implications in understanding the role of thermosensitive ion channels in bone formation and functions, and the TRPV1 modulator-releasing hydrogel may have application in bone tissue engineering and other biomedical sectors.